(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

CAS: 53101-49-8

Ref. 3D-DCA10149

Produktinformation

• Name: (R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
• Synonyme: (2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carboxylic acid
• CAS: 53101-49-8

Beschreibung

(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (HMCA) is a supplement that is used to treat cancer. HMCA is an acetyl donor and can be used as a substitute for erythromycin. HMCA was shown to inhibit the growth of human breast cancer cells in culture by reacting with lorazepam and lipase to form a reactive intermediate. This compound has been immobilized on ion-exchange resin for use in biodegradable materials and can be used for the treatment of chronic obstructive pulmonary disease (COPD).

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 250.29 g/mol
• Formel: C₁₄H₁₈O₄
• Reinheit: Min. 95%